Evidence map›Paper›PMID 41254677›Full record

ArticleStem cell research & therapy2025

Synergistic promotion of bone regeneration through co-culture of endothelial cells with mesenchymal stem cells in endochondral ossification organoids.

Yiqi Su, Zihao He, Jiaojiao Li, Qianqian Chen, Du Wang, Zhen Yang, Ye Yuan, Long Chen, Fanhao Ye, Dan Xing and 2 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yiqi Su *Arthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Zihao He *Arthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Jiaojiao LiSchool of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Sydney, NSW, 2007, Australia.
Qianqian ChenThird Clinical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Du WangArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Zhen YangArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Ye YuanArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Long ChenArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Fanhao YeArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China.
Dan XingArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China. xingdan@bjmu.edu.cn.
Hui LiArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China. doctor_li@bjmu.edu.cn.
Jianhao LinArthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, China. linjianhao@pkuph.edu.cn.

Funding

National Key Research and Development Program of China 2022YFC2503103National Key Research and Development Program of China 2024YFA1108603National Natural Science Foundation of China 82302776Natural Science Foundation of Beijing Municipality L222087Natural Science Foundation of Beijing Municipality L232094Natural Science Foundation of Beijing Municipality L244019Peking University People's Hospital Scientific Research Development Funds RDGS2023-04Peking University People's Hospital Scientific Research Development Funds RDX2023-12Peking University People's Hospital Scientific Research Development Funds RS2024-04
6 · The paper itself

Abstract

backgroundEndochondral ossification (ECO) is essential for bone regeneration, involving cartilage formation, hypertrophy, angiogenesis, and ossification. Co-culturing mesenchymal stem cells (MSCs) with endothelial cells (ECs) shows potential to enhance bone regeneration but has not been effectively applied to ECO strategy.

methodsWe examined the synergistic effects of MSCs and ECs on chondrogenesis, osteogenesis, and angiogenesis, followed by transcriptomic analysis. ECO organoids were formed in the scaffolds, and a critical-sized calvarial bone defect model was used for in vivo evaluation.

resultsCo-culture of ECs and MSCs promoted osteogenic differentiation and hypertrophic chondrogenic differentiation of MSCs. The ECO organoids exhibited enhanced vascularization and improved mineralization. In vivo, the co-culture group showed superior vascularization and bone repair compared to the MSCs-only group.

conclusionsCo-culturing ECs with MSCs in ECO organoids enhances bone regeneration, offering a promising alternative to traditional tissue engineering strategies. This approach may improve therapeutic outcomes by promoting endochondral bone formation.

Indexed as

Bone RegenerationEndothelial CellsMesenchymal Stem CellsOrganoidsOsteogenesisAnimalsCell DifferentiationChondrogenesisCoculture TechniquesHumansMiceNeovascularization, PhysiologicTissue EngineeringBone repairEndochondral ossificationEndothelial cellsMesenchymal stem cellsOrganoid

Identifiers

PMID41254677
PMCPMC12625428

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.